STOCK TITAN

Myomo (MYO) Stock News

MYO NYSE

Welcome to our dedicated page for Myomo news (Ticker: MYO), a resource for investors and traders seeking the latest updates and insights on Myomo stock.

Myomo Inc. develops and markets wearable medical robotics for people with neurological disorders and upper-limb paralysis. Its MyoPro product line is a powered upper-limb orthosis that uses non-invasive EMG sensors to support weakened or paralyzed arms in patients with conditions such as stroke, brachial plexus injury, traumatic brain injury, spinal cord injury and other neuromuscular disease or injury.

Company news commonly covers MyoPro orders, insurance authorizations, patient-pipeline trends, revenue from recurring patient sources, market-access relationships with orthotics and prosthetics providers, and product-development updates such as the Myomo Mobile App. Updates also include clinical research evaluating MyoPro, operating results, direct-billing activity, international sales channels and board governance changes.

Rhea-AI Summary

Myomo, Inc. (NYSE American:MYO), a company focused on wearable medical robotics, has been invited to present at the MicroCap Rodeo Best Ideas Bowl from October 13-16, 2020. Myomo's presentation is scheduled for October 13 at 4:30 p.m. ET, featuring CEO Paul Gudonis and CFO David Henry. The conference will showcase 25 top investment ideas from institutional investors, aiming to identify opportunities for alpha generation. Myomo's MyoPro product line aids those with upper-limb paralysis, enabling daily activities and promoting independence.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.94%
Tags
conferences
-
Rhea-AI Summary

Myomo, Inc. (NYSE American:MYO) announced its participation in the LD 500 investor conference on September 2, 2020, at 11:00 a.m. EDT. The presentation will be led by CEO Paul Gudonis and CFO David Henry, streamed to a virtual audience. This marks a significant opportunity for Myomo to showcase its advancements in wearable medical robotics that aid those with neurological disorders. The LD 500 conference runs from September 1-4, and interested parties can register for the real-time presentation online, with a replay available on Myomo's website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.26%
Tags
conferences

FAQ

What is the current stock price of Myomo (MYO)?

The current stock price of Myomo (MYO) is $0.7782 as of May 12, 2026.

What is the market cap of Myomo (MYO)?

The market cap of Myomo (MYO) is approximately 32.8M.